Long-term sequelae of spontaneous axillary-subclavian venous thrombosis.
BACKGROUND
The frequency and severity of post-thrombotic sequelae after spontaneous axillary-subclavian venous thrombosis remain poorly known.


OBJECTIVE
To determine the late sequelae of conventionally treated spontaneous axillary-subclavian venous thrombosis.


METHODS
Cross-sectional study.


METHODS
University department of vascular medicine.


METHODS
54 patients seen during an 18-year period (mean follow-up, 5 years).


METHODS
Scores for the severity of post-thrombotic symptoms were graded on a numerical rating scale ranging from 0 to 10 and on a 6-point verbal rating scale. Ultrasonographic sequelae were classified as grade 0, normal flow; grade 1, moderate obstruction; or grade 2, severe obstruction or occlusion.


RESULTS
Verbal scores were "nil/negligible" in 47% of patients and "severe/intolerable" in 13%; numerical scores were 0 to 3 in 78% of patients and 7 to 10 in 9%. Grade 2 ultrasonographic sequelae were found in 22% of cases. No relation was seen between ultrasonographic sequelae and symptom severity scores.


CONCLUSIONS
The overall clinical outcome of spontaneous axillary-subclavian venous thrombosis is good, and there is no relation between the severity of late symptoms and ultrasonographic sequelae.
Héron
E
E
Hôpital Broussais and Hôpital Saint-Joseph, Paris, France.
Lozinguez
O
O
Emmerich
J
J
Laurian
C
C
Fiessinger
J N
JN
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D001367:Axillary Vein / Q000000981:diagnostic imaging / Q000503:physiopathology; D003430:Cross-Sectional Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012039:Regional Blood Flow / Q000502:physiology; D013350:Subclavian Vein / Q000000981:diagnostic imaging / Q000503:physiopathology; D016896:Treatment Outcome; D014463:Ultrasonography; D020246:Venous Thrombosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology
D000925:Anticoagulants